Reuters
Published May 26, 2021 12:36AM ET
Updated May 26, 2021 04:42AM ET
TAIPEI (Reuters) -The top U.S. diplomat in Taipei said on Wednesday he was confident Taiwan could control a spike in COVID-19 cases, noting its infection numbers remained quite low, and that they were in talks on vaccines though did not say shots were on the way.
After months of relative safety, Taiwan is battling a surge in domestic COVID-19 cases, but has only vaccinated around 1% of its more than 23 million people.
Taiwan's government says millions more vaccines are on the way, and last week the health minister spoke to his U.S. counterpart to ask for help after President Joe Biden said he would send at least 20 million more COVID-19 vaccine doses abroad by the end of June.
Brent Christensen, the outgoing de facto U.S. ambassador in Taipei, told reporters Taiwan's management of the pandemic had impressed everyone globally.
"We are very confident in the ability of Taiwan's health authorities to contain the latest outbreak," he said.
"I'd also point out that many of Taiwan's neighbours in the region are also experiencing outbreaks and Taiwan's infection numbers are still among the lowest in the world," Christensen added.
Criteria for releasing U.S. vaccines were still being developed, but included the level of infection, the capacity of the healthcare system and the level of vaccination, he said.
"We know that Taiwan's own vaccines will be available in coming months and I can assure everyone that we are engaging with Taiwan at all levels."
Like most countries, the United States has no formal diplomatic ties with Chinese-claimed Taiwan, but is its strongest backer on the world stage and a major source of arms.
China has offered Taiwan vaccines, but the government has rejected the idea, saying Beijing has not provided adequate information about its shots and has in any case tried blocking Taiwan's access to vaccines internationally.
Taiwan President Tsai Ing-wen said later on Wednesday that China was responsible for blocking a deal with Germany's BioNTech SE (NASDAQ:BNTX) for vaccines.
Taiwan has ordered more than 20 million vaccines from AstraZeneca (NASDAQ:AZN) Plc and Moderna (NASDAQ:MRNA) Inc as well as developing its own shots. So far only a little more than 700,000 AstraZeneca doses have arrived.
China's Taiwan Affairs Office said Taiwan was using "many different excuses" to block its people from getting vaccines from China.
Referring to China, Christensen said lately the threats against Taiwan had felt relentless, and pulled out a pineapple to place on his podium, a reference to Beijing's decision in February to ban imports from the island of the fruit.
"I think we can all remember a recent example of Taiwan demonstrating its resolve and unity in the face of bullying. Bullying quickly backfired."
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.